[Cutaneous pseudolymphoma as an alternative presentation of IgG4 related disease].
暂无分享,去创建一个
J. Malfuson | T. de Revel | A. Cremades | J. Konopacki | H. Eddou | T. Le Guyadec | P. Saint Blancard
[1] K. Uchida,et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease , 2011, Journal of Gastroenterology.
[2] R. Start,et al. IgG4-related disease – a modern mimic of malignancy , 2010 .
[3] J. Stone,et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. , 2010, Arthritis and rheumatism.
[4] T. Shimosegawa,et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP , 2010, Journal of Gastroenterology.
[5] S. Yuen,et al. IgG4-related Sclerosing Disease: A Potential New Etiology of Cutaneous Pseudolymphoma , 2009, The American journal of surgical pathology.
[6] T. Shimosegawa,et al. Standard steroid treatment for autoimmune pancreatitis , 2009, Gut.
[7] H. Asaoku,et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease , 2009, Modern Pathology.
[8] Y. Nakanuma,et al. Th2 and regulatory immune reactions are increased in immunoglobin G4‐related sclerosing pancreatitis and cholangitis , 2007, Hepatology.
[9] T. Nikaido,et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.
[10] L. Daniel,et al. Maladie systémique associée aux IgG4 : une pathologie émergente ? Mise au point et revue de la littérature , 2011 .